Renate Gehwolf

Dr. Renate Gehwolf


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 April 2019 in Cells
Verified
Journal Article
Open access
PDF file
RGRenate Gehwolf
Renate Gehwolf
BSBettina Schwemberger
Bettina Schwemberger
MJMalik Jessen
Malik Jessen
SKStefanie Korntner
Stefanie Korntner
AWAndrea Wagner
Andrea Wagner
ATAndreas Traweger
Andreas Traweger
Tendinopathy is accompanied by a cascade of inflammatory events promoting tendon degeneration. Among various cytokines, interleukin-1β plays a central role in driving catabolic processes, ultimately resulting in the activation of matrix metalloproteinases and a diminished collagen synthesis, both of which promote tendon extracellular matrix degradation. Pulsed electromagnetic field (PEMF) therapy is often used for pain management, osteoarthritis, and delayed wound healing. In vitro PEMF treatment of tendon-derived cells was shown to modulate pro-inflammatory cytokines, potentially limiting their catabolic effects. However, our understanding of the underlying cellular and molecular mechanisms remains limited. We therefore investigated the transcriptome-wide responses of Il-1β-primed rat Achilles tendon cell-derived 3D tendon-like constructs to high-energy PEMF treatment. RNASeq analysis and gene ontology assignment revealed various biological processes to be affected by PEMF, including extracellular matrix remodeling and negative regulation of apoptosis. Further, we show that members of the cytoprotective Il-6/gp130 family and the Il-1β decoy receptor Il1r2 are positively regulated upon PEMF exposure. In conclusion, our results provide fundamental mechanistic insight into the cellular and molecular mode of action of PEMF on tendon cells and can help to optimize treatment protocols for the non-invasive therapy of tendinopathies.

8 February 2019
Verified
Book Chapter
Closed access
PDF file
RGRenate Gehwolf
Renate Gehwolf
GSGabriel Spitzer
Gabriel Spitzer
AWAndrea Wagner
Andrea Wagner
CLChristine Lehner
Christine Lehner
NWNadja Weissenbacher
Nadja Weissenbacher
ATAndreas Traweger
Andreas Traweger

Verified
Journal Article
Open access
PDF file
MOMichaela Oeller
Michaela Oeller
HJHeidi Jaksch-Bogensperger
Heidi Jaksch-Bogensperger
MTMarkus Felix Templin
Markus Felix Templin
RGRenate Gehwolf
Renate Gehwolf
EREva Rohde
Eva Rohde
SLSandra Laner-Plamberger
Sandra Laner-Plamberger
Human platelet lysate (HPL) is an efficient alternative for animal serum supplements, significantly enhancing stromal cell proliferation. However, the molecular mechanism behind this growth-promoting effect remains elusive. The aim of this study was to investigate the effect of HPL on cell cycle gene expression in different human stromal cells and to identify the main key players that mediate HPL’s growth-enhancing effect. RT-qPCR and an antibody array revealed significant upregulation of cell cycle genes in stromal cells cultured in HPL. As HPL is rich in growth factors that are ligands of tyrosine kinase receptor (TKR) pathways, we used TKR inhibitors and could significantly reduce cell proliferation. Genome profiling, RT-qPCR and Western blotting revealed an enhanced expression of the transcription factors signal transducer and activator of transcription 3 (STAT3) and MYC, both known TKR downstream effectors and stimulators of cell proliferation, in response to HPL. In addition, specifically blocking STAT3 resulted in reduced cell proliferation and expression of cell cycle genes. Our data indicate that HPL-enhanced cell proliferation can, at least in part, be explained by the TKR-enhanced expression of STAT3 and MYC, which in turn induce the expression of genes being involved in the promotion and control of the cell cycle.

1 June 2018 in Biotechnology Reports
Verified
Journal Article
Open access
HJHeidi Jaksch-Bogensperger
Heidi Jaksch-Bogensperger
AHAnna Hammerschmid
Anna Hammerschmid
LALudwig Aigner
Ludwig Aigner
ETEugen Trinka
Eugen Trinka
RGRenate Gehwolf
Renate Gehwolf
Sebastien Couillard-DespresSebastien Couillard-Despres
Sebastien Couillard-Despres
•The receptor tyrosine kinase (RTK) Axl and its ligand Gas6 are critically involved in the pathogenesis of high-grade glioma (HGG). Both proteins were found to be overexpressed e.g. in tumor cells, mediating cell proliferation and migration as well as tumor angiogenesis and neuroinflammation. The extracellular domain of Axl (sAxl) and Gas6 were found in the peri-tumoral edema and blood of animals as well as in human glioma tissue. Therefore, we monitored the level of sAxl and Gas6 in human blood samples. To increase the sensitivity of protein detection beyond commonly used standard methods we preliminary tested the innovative Proseek Single-Plex Protein Assay Kit System from Olink Bioscience together with new antibodies against the soluble RTK sAxl and its ligand Gas6. We conclude that the Proseek method is a highly sensitive and fast procedure that can be used as a possible powerful tool compared to routinely used ELISA-methods.

1 February 2014 in Journal of Immunological Methods
Verified
Journal Article
Closed access
RGRenate Gehwolf
Renate Gehwolf
EBElisabeth Band
Elisabeth Band
ATAndrea Trost
Andrea Trost
BIBernhard Iglseder
Bernhard Iglseder
ETEugen Trinka
Eugen Trinka
AHAndrea Harrer
Andrea Harrer

4 July 2019 in bioRxiv
Verified
Preprint
Open access
PDF file
CLChristine Lehner
Christine Lehner
GSGabriel Spitzer
Gabriel Spitzer
RGRenate Gehwolf
Renate Gehwolf
AWAndrea Wagner
Andrea Wagner
NWNadja Weissenbacher
Nadja Weissenbacher
ATAndreas Traweger
Andreas Traweger
Tendon disorders frequently occur and recent evidence has clearly implicated the presence of immune cells and inflammatory events during early tendinopathy. However, the origin and properties of these cells remain poorly defined. Therefore, the aim of this study was to determine the presence of myleoid cells in healthy rodent and human tendon tissue and to characterize them. Using various transgenic reporter mouse models, we demonstrate the presence of tendon cells in the dense matrix of the tendon core expressing the fractalkine (Fkn) receptor CX3CR1 and its cognate ligand CX3CL1/Fkn. Pro-inflammatory stimulation of 3D tendon-like constructs in vitro resulted in a significant increase in the expression of IL-1β, IL-6, Mmp3, Mmp9, Cx3cl1, and epiregulin which has been reported to contribute to inflammation, wound healing, and tissue repair. Furthermore, we demonstrate that inhibition of the fractalkine receptor blocked tendon cell migration in vitro and show the presence of CX3CR1/CX3CL1/EREG expressing cells in healthy human tendons. Taken together, we demonstrate the presence of CX3CL1+/CX3CR1+ “tenophages” within the healthy tendon proper potentially fulfilling surveillance functions in tendons. Summary Statement: Here, we demonstrate the presence of a macrophage-like, CX3CL1/CX3CR1-expressing cell population within the healthy tendon proper potentially fulfilling a surveillance function.